HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

IDXX

IDEXX Laboratories, Inc. (Nasdaq 100, S&P 500)

Healthcare — Diagnostics & Research

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Buy 2.2 / 5 12 analysts
$517.75
$-4.44 (-0.85%)
Target: $701.33 (35.5%)

Price History

52-Week Range
Sign in to add IDXX to a watchlist or set price alerts.

Fundamentals

Market Cap$40.79B
P/E Ratio (TTM)37.14
Forward P/E30.93
EPS (TTM)$13.94
Dividend Yield-
Profit Margin25.03%
Revenue Growth9.70%
ROE74.21%
Debt/Equity67.97
Recommendation Buy 2.2
Analyst Target$701.33
Analysts12
Next Earnings Nov 2, 2026 BMO
Indexes Nasdaq 100 S&P 500

Technical Indicators

RSI (14)58.6
Beta1.54
SMA 20$517.86
SMA 40$539.33
52-Week High$769.98
52-Week Low$500.61
50-Day Avg$544.76
200-Day Avg$589.79
Avg Volume570.9K
Volume319.3K

Performance Analysis

BULLISH

IDXX shows predominantly bullish signals based on its fundamentals and technicals.

+ Trading near its 52-week low ($500.61), which could present a value opportunity.
+ RSI at 58.6 shows positive momentum.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
~ Modest revenue growth of 9.7% year-over-year.
+ Healthy profit margin of 25.0%.
+ Wall Street consensus is "Buy" from 12 analysts.
+ Average analyst target of $701.33 implies 35.5% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Oct 01, 2026 21:01 UTC

Back to Screener Export Report